Cholestasis Reversal: Efficacy of IV Fish Oil

NCT00910104 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Parenteral Nutrition Associated Liver Disease
Short Bowel Syndrome
Gastrointestinal Disease

Interventions

DRUG: Omegaven®

Sponsor

Mark Puder